Results 221 to 230 of about 3,030,015 (277)

Next‐Generation CAR‐T Cell Therapy: From Modular Design to Clinical Expansion

Exploration, EarlyView.
Over the past decades, chimeric antigen receptor (CAR)‐T cell therapy has evolved from a linear engineering concept into a powerful yet constrained immunotherapy, limited by tumour microenvironment barriers, immune evasion, and manufacturing complexity.
Yuesong Bai, Jintao Qin, Zongjun Dai, Ran Yan, Yong Yang, Wenguang Wang   +5 more
wiley   +1 more source

Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg

European Journal of Rheumatology, 2020
Courtney Crayne, Randy Q. Cron
doaj  

Griscelli Syndrome Type 2 Revealed by Macrophage Activation Syndrome: Two Cases From the Same Family. [PDF]

Cureus
Halimy B, Radi A, Laaraje A, Amale H, Abilkassem R.   +4 more
europepmc   +1 more source

Anti‐Inflammatory Effects of Punicic Acid and Its Molecular Mechanisms in RAW264.7 Cells and Zebrafish

Food Safety and Health, EarlyView.
Punicic acid (PA) was enriched and purified from PSO by molecular distillation with significant anti‐inflammatory activity to RAW264.7 cells, as well as to zebrafish. Anti‐inflammatory mechanism involved regulating NF‐κB and MAPK signaling pathways. ABSTRACT Punicic acid (PA) is the main fatty acid in pomegranate seeds, which shows multiple biological ...
Mengqi Zhang, Caiyun Feng, Mengyao Zhu, Xu Guo, Yingying Chen, Wenwen Hu, Fei Dong, Jinyue Sun, Chao Liu   +8 more
wiley   +1 more source

Shock in Adult-Onset Still's Disease Complicated by Macrophage Activation Syndrome: Clinical Characteristics and Prognosis of 14 Patients. [PDF]

Int J Hepatol
Li D, Cheng L, Zhang Y, Qian L.
europepmc   +1 more source

Macrophage activation syndrome complicating adult-onset Still's disease: the case for standardized guidelines. [PDF]

Proc (Bayl Univ Med Cent)
Vaseer S.
europepmc   +1 more source

Macrophage Activation Syndrome Revealing Hodgkin Lymphoma: A Pediatric Case Report. [PDF]

Cureus
Hared Bouh A, Moussa Sougueh O, Miqdadi A, Al Ammari I, Dini N.   +4 more
europepmc   +1 more source

Emapalumab as a Life-Saving Therapy for Macrophage Activation Syndrome in Refractory Systemic Juvenile Idiopathic Arthritis with Trisomy 21. [PDF]

Turk Arch Pediatr
Akay N, Aslan E, Gul U, Kilic Konte E, Yildiz M, Sahin S.   +5 more
europepmc   +1 more source

Application of machine learning techniques to explore the occurrence of macrophage activation syndrome in Still's disease: results from the GIRRCS AOSD Study Group and the AIDA Network Still's Disease Registry. [PDF]

Front Immunol
Ruscitti P, Masedu F, Vitale A, Caggiano V, Di Cola I, Atzeni F, Sbalchiero J, Lopalco G, Iannone F, Morrone M, Iacono D, Riccio F, Visconti M, Gaggiano C, Caso F, Emmi G, Hinojosa-Azaola A, Torres-Ruiz J, Martín-Nares E, Guggino G, La Barbera L, Batu ED, Ozen S, Sfikakis PP, Navarini L, Costa L, Tufan A, Cakir IY, Perosa F, Hernández-Rodríguez J, Prete M, Dagna L, Campochiaro C, Ursini F, Sfriso P, Bindoli S, Giardini HAM, Fotis L, Kourtesi K, Ragab G, Ghanema M, Saad MA, Direskeneli H, Karamanakos A, Conforti A, La Torre F, Frassi M, Govoni M, Parronchi P, Sarzi-Puttini P, Maggio MC, Bugatti S, De Stefano L, Pelizza J, Bartoloni E, Rigante D, Iagnocco A, Viapiana O, Wiesik-Szewczyk E, Makowska J, Gündüz ÖS, Erten Ş, Ogunjimi B, Sebastiani GD, Del Giudice E, Biancalana E, Conti G, AlMaghlouth IA, Breda L, Gidaro A, Barone P, Olivieri AN, Carubbi F, De Paulis A, Chimenti MS, Lo Gullo A, Tharwat S, Thabet M, Moshrif A, Alessio M, Mauro A, Suzon B, Pucino V, Boyarchuk O, Kovalchuk T, Bes C, Deniz R, Al-Mayouf SM, Cipriani P, Valenti M, Balistreri A, Fabiani C, Ciccia F, Montecucco C, Giacomelli R, Frediani B, Cantarini L.   +96 more
europepmc   +1 more source